The Marketing Declaration of HAISCO’s Novel Analgesic for Diabetic Peripheral Neuralgia Treatment

This week, the marketing application of HAISCO's first-in-class HSK16149 Capsule was submitted, presumably for the treatment of diabetic peripheral neuralgia. Several clinical trials achieved positive results, while Alpine Immune terminated two clinical trials of davoceticept due to the death of patients. More pharma news of this week worthy of attention covers topics on drug review, R&D, and Listing. You can get more industry insights and firsthand market information from China to the globe at  PharmaSources.com

 

Online registration for CPHI & PMEC China Virtual Expo Connect is in full swing. Over the past three weeks, more than 800 users have been ready to connect and learn in the world’s second largest pharmaceuticals market. Whether or not you plan to be at CPHI & PMEC in Shanghai, you can join Virtual Expo Connect for free. So, even if you can’t attend the live event, you don’t have to miss out. If you can attend, it’s a great opportunity to extract maximum value from your trip by boosting your networking and visibility. Get it registered now and hope you enjoy your VEC journey. Learn more about the event and get your free pass here: CPHI & PMEC China Virtual Expo Connect (pharmasources.com)